News

News


25 Jul 2011
Vilchèze C, Baughn AD, Tufariello J, Leung LW, Kuo M, Basler CF, Alland D, Sacchettini JC, Freundlich JS, Jacobs WR Jr. Novel Inhibitors of InhA Efficiently Kill Mycobacterium tuberculosis under Aerobic and Anaerobic Conditions. Antimicrob Agents Chemother. 2011 Aug;55(8):3889-98. Epub 2011 May 31...
20 Jul 2011
Mike Mandelbaum is Chief Executive of TB Alert, which is the UK’s National and International Tuberculosis charity – the only British charity working solely on fighting TB in the UK and overseas. TB Alert is a young charity, registered in late 1998 and launched at the Houses of Parliament on World...
18 Jul 2011
BiBianco MV , Blanco FC, Imperiale B, Forrellad MA , Rocha RV, Klepp LI , Cataldi AA , Morcillo N, Bigi F. Role of P27 -P55 operon from Mycobacterium tuberculosis in the resistance to toxic compounds. BMC Infectious Diseases. 2011 Jul 16; 11:195. [Epub ahead of print] This week, we present an...
13 Jul 2011
Click here for full report A report entitled “An Evaluation of Drug-resistant TB Treatment Scale-up” was issued by the Médecins Sans Frontières (MSF), Partners in Health (PIH), and Treatment Action Group (TAG) on 7 July, 2011 and looks at the factors contributing to the slow progress of efforts to...
11 Jul 2011
Diacon AH, Dawson R, Hanekom M, Narunsky K, Venter A, Hittel N, Geiter LJ, Wells CD, Paccaly AJ, Donald PR. Early bactericidal activity of delamanid (OPC-67683) in smear-positive pulmonary tuberculosis patients. Int J Tuberc Lung Dis . 2011 Jul; 15 ( 7 ):949-54. This week, we review a recent...
6 Jul 2011
In the July 7 issue of the New England Journal, two articles and an editorial on latent TB and TB prevention are included: Articles Martinson NA, et al “New regimens to prevent tuberculosis in adults with HIV infection” N Engl J Med 2011; 365: 11-20. Madhi SA, et al “Primary isoniazid prophylaxis...
27 Jun 2011
A Dowsett, Health Protection Agency/Science Photo Library Vento S, Lanzafame M. Tuberculosis and cancer: a complex and dangerous liaison. Lancet Oncol. 2011 Jun;12(6):520-2. This week we review a commentary on the correlations between tuberculosis and cancer, specifically lung cancer. There are...
20 Jun 2011
Kevin DA, Meujo DAF, Hamann MT. Polyether ionophores: broad-spectrum and promising biologically active molecules for the control of drug-resistant bacteria and parasites. Expert Opinion on Drug Discovery 2009 Feb;4(2):109-146(38). doi:10.1517/17460440802661443. During this week’s TB R&D Weekly...
13 Jun 2011
Louw GE, Warren RM, Gey van Pittius NC, Leon R, Jimenez A, Pando RH, McEvoy CR, Grobbelaar M, Murray M, van Helden PD, Victor TC. Rifampicin Reduces Susceptibility to Ofloxacin in Rifampicin Resistant Mycobacterium tuberculosis through Efflux. Am J Respir Crit Care Med. 2011 Apr 21. [Epub ahead of...
8 Jun 2011
These are the facts (source: Time to Act-Save a million lives by 2015 brochure ) : At least one out of three people in the world has latent TB infection, which increases the risk of becoming ill with TB. People living with HIV have an estimated 20 to 30 times greater risk of developing active TB...
6 Jun 2011
Dr. Armand Van Deun Summary: This week’s interview is with Dr. Armand Van Deun who was the recipient of the 2010 Stop TB Partnership-Kochon Foundation prize . Last year, Dr. Van Deun, et al., published an article in the American Journal of Respiratory and Critical Care Medicine entitled “ Short,...
2 Jun 2011
Stop TB Partnership – Kochon Prize 2011 Call for Nominations The Stop TB Partnership Kochon Prize supports the global fight against tuberculosis (TB). The Prize, consisting of a medal and US$ 65 000, is awarded once a year to persons, institutions, or organizations that have made a highly...
1 Jun 2011
MIchael D. Iseman Dr. Michael D. Iseman, a world renowned pulmonologist and leading expert on tuberculosis has joined Oxford Immunotec as the Senior Scientific Advisor. To read full story, click here . In May 2010, the WGND had the honor of interviewing Dr. Iseman in our “Voices from the Fight to...
25 May 2011
Operation ASHA is an NGO based out of New Delhi, India and Chicago, USA Summary: Shelly Batra is a renowned gyn & obs surgeon in New Delhi. She has a deep desire to serve the community. She has worked pro-bono for dissemination of medical information with many television stations and newspapers...
24 May 2011
Please take a minute and help us choose a new logo for the Stop TB Partnership’s Working Group on New Drugs (WGND). Since our inception in 2001, the WGND has evolved and expanded greatly. Through our membership and activities, we have been able to contribute to the critical collaborations and...

Pages